J. B. Chemicals & Pharmaceuticals Board Meeting to Approve Unaudited Financial Results

J. B. Chemicals & Pharmaceuticals has announced a board meeting scheduled for November 11, 2025. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half-year ending on September 30, 2025. Investors are awaiting the results, which will provide insights into the company’s performance.

Board Meeting Announcement

J. B. Chemicals & Pharmaceuticals has announced that a meeting of the Board of Directors will be held on November 11, 2025.

Agenda of the Meeting

The primary agenda of the meeting is to consider and approve the unaudited financial results for the quarter and half-year which concluded on September 30, 2025.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!